$0.4238
-0.0237-5.3%
Last update: Oct 13, 6:33 PM
$0.4234
-0.0241-5.39%

Pasithea Therapeutics (KTTA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.16 | $-0.45 | $-0.45 | — |
| Actual | $-0.16 | $-0.12 | $-0.89 | $-0.41 |
| Surprise | 0.00% | +73.3% | -97.8% | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.21 | $-0.25 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.16 | $-0.16 | 0.00 % |
| Q1 | May 15, 2026 | $-0.12 | $-0.45 | 73.3 % |
| Q4 | Mar 30, 2026 | $-0.89 | $-0.45 | -97.8 % |